Key opinion leaders review case scenarios in Targeted Oncology live case-based peer perspective discussions.
Kim Evaluates Atezolizumab and Durvalumab for ES-SCLC
September 9th 2020Edward Kim, MD, chair, Department of Solid Tumor Oncology, Levine Cancer Institute in Charlotte, NC, discussed the use of atezolizumab and durvalumab as treatment of a 73-year-old female patient with extensive-stage small cell lung cancer during a virtual Case Based Peer Perspective event.